Clinical trial

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

NCT05462535

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-02-26

PhaseN/A

Study timeline

Study start (actual)2018-02-26Date precision: day

Registry last updated2022-07-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension,Essentialunresolved

Interventions

Amosartan Plus Tab.DRUG

Sponsors & collaborators

Hanmi Pharmaceutical Company Limitedlead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05462535 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.